Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Medical Device

Cardinal Health completes CareFusion spinoff

This article was originally published in The Gray Sheet

  • News

Executive Summary

Healthcare supply chain services firm Cardinal Health completes the planned spinoff of its clinical and medical products business Sept. 1 through a pro rata distribution of 81% of CareFusion stock to Cardinal Health shareholders. Cardinal Health plans to divest its remaining 19% stake in CareFusion within five years. Representing roughly $4.5 billion in annual sales, CareFusion includes Alaris infusion pumps, Avea respirators, Pyxis medication dispensing systems, MedMined electronic infection surveillance services, and ChloraPrep skin preparation products. Spinoff of the San Diego business has been in the works since summer 2008 (1"The Gray Sheet" Aug. 11, 2008)

Table

View full table

Topics

Tags:
Medical Device
Latest Headlines

Epitel Gets 510(k) Clearance On Remote EEG Technology

Valuable Health Data Sources For Medtech Industry Come A Step Closer In The EU

Rise In Class I Device Recalls A ‘Grave Concern,’ Says FDA’s Anne Reid

Discreet Gait Freezing Solution Brings Therapy With The Tap Of An Apple Watch

See All
UsernamePublicRestriction

Register

MT027864

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By